Dr. Zheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Dr
H088
Hershey, PA 17033Phone+1 717-531-6585Fax+1 717-531-0429
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2007 - 2010
Capital University of Medical SciencesClass of 1995
Certifications & Licensure
PA State Medical License 2007 - 2026
CA State Medical License Active through 2013- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Quantitative peripheral live single T-cell dynamic polyfunctionality profiling predicts lung cancer checkpoint immunotherapy treatment response and clinical outcomes.Zuan-Fu Lim, Xiaoliang Wu, Lin Zhu, Heidar Albandar, Maria Hafez
Translational Lung Cancer Research. 2024-12-31 - Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed Chimerism.Ruoheng Zhang, Yimeng Shang, Joseph Cioccio, Kevin Rakszawski, Myles Nickolich
The Journal of Molecular Diagnostics. 2024-12-01 - Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02.Akshita Khosla, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej
Blood Transfusion = Trasfusione Del Sangue. 2024-11-01
Abstracts/Posters
- Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute LeukemiaHong Zheng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particular...Hong Zheng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Graft-Versus-Host Disease Causes the Failure of Donor Hematopoietic Progenitor Cells to Reconstitute Plasmacytoid Dendritic Cells That Promote Tolerance of Donor T Cel...Hong Zheng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Effect of Avelumab to Immune Response in AML: A Phase I Study of Avelumab in Combination with Decitabine As First Line Treatment of Unfit Patients61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Multi-Dimensional Analysis of Immune Signature Predicts Response to Decitabine Treatment in Elderly Patients with AML2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Cost-Effectiveness of Different Surgical Treatment Approaches for Early Breast Cancer: A Retrospective Matched Cohort Study from ChinaFebruary 2nd, 2021
Researchers Discover a Potential Biomarker for AML Relapse After Stem Cell TransplantSeptember 24th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
